News for Evotec SE (EVT.DE)

Ongoing strategic partnership advances joint pipeline in neurodegeneration researchEvotec receives a $20 million payment to further progress research HAMBURG, D

Laetitia Rouxel steps down as Chief Financial Officer effective 28 February 2025Paul Hitchin appointed to succeed as Chief Financial Officer effective 1 March 2

PR NewswireSYDNEY, Jan. 14, 2025 SYDNEY, Jan. 14, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-fo

Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering

PR NewswireSYDNEY, Jan. 10, 2025 SYDNEY, Jan. 10, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-fo

PR NewswireSYDNEY, Dec. 31, 2024 SYDNEY, Dec. 31, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development comp

U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Friday. Shares of Ingles Markets, Incorporated IMKTA fell in t...

Novo Nordisk and Evotec select three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center

Dr Craig Johnstone steps down as Chief OperatingOfficer effective 31 December 2024Distribution of responsibilities internally HAMBURG, GERMANY / ACCESSWIRE / No

Halozyme retracts Evotec acquisition offer; shares rise as Evotec remains focused on standalone growth. Halozyme's stock impacted by earlier bid news.

Halozyme stock rises after withdrawing its €2B acquisition offer for Evotec, while reaffirming strong growth outlook for 2024.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) saw its shares rise on Friday after the company announced it was withdrawing its proposal to acquire Evotec SE (NASDAQ:EVO) for 11 euro ($11.44) per share in cash, implying a fully diluted equity value of 2.0 billion euro. This move comes after prolonged efforts to engage with Evotec, which expressed its desire to remain independent, Halozyme said. In addition to this, Halozyme reaffirmed its strong business outlook, with its 2024 guidance signaling cont

HAMBURG, GERMANY / ACCESSWIRE / November 22, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480)(NAS

U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Friday's. Shares of Intuit Inc. INTU fell sharply in today's p...

In Germany, the economic growth is based on industry. According to Deutschland.de, Germany's manufacturing industry contributed 26.6% to the country's gross value in 2021.

Regencell Bioscience Holdings (RGC) experienced a significant stock drop of 5.46%. The stock price fell to $6.54 with a trading volume of 32,386 shares and a tu

In-vivo CRO industry is projected to witness a CAGR of 7.8% during the period 2024-2032. This growth can be attributed to stringent regulatory landscape...

U.S. stocks were lower, with the Dow Jones index falling around 300 points on Monday. Shares of Integra LifeSciences Holdings Corporation IART rose sharply dur...

North Carolina-based Scorpius Holdings, Inc. (SCPX) is down over 79 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.